|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 AUD | 0.00% |
|
0.00% | +29.87% |
| Apr. 10 | Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024 | CI |
| Apr. 10 | Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18% | MT |
Immuron Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 1.8 million compared to AUD 0.765193 million a year ago. Net loss was AUD 3.79 million compared to AUD 2.85 million a year ago.
Basic loss per share from continuing operations was AUD 0.0166 compared to AUD 0.0125 a year ago. Diluted loss per share from continuing operations was AUD 0.0166 compared to AUD 0.0125 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.87% | 14.96M | |
| -3.45% | 87.17B | |
| +2.76% | 40.1B | |
| -16.16% | 31.38B | |
| +57.86% | 25.12B | |
| -15.73% | 15.59B | |
| -9.12% | 12B | |
| -42.56% | 11.8B | |
| -18.58% | 11.8B | |
| +6.89% | 8.81B |
IMMURON LIMITED 
